Plasma cholesterol: An influencing factor in red blood cell oxygen release and cellular oxygen availability

被引:26
作者
Buchwald, H
Menchaca, HJ
Michalek, VN
Rohde, TD
Hunninghake, DB
O'Dea, TJ
机构
[1] Univ Minnesota, Dept Surg, Minneapolis, MN 55455 USA
[2] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA
关键词
D O I
10.1016/S1072-7515(00)00704-3
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: A fairly immediate reduction in angina pectoris symptoms after cholesterol lowering has been described. Our previous findings in rabbits and in a four-patient human pilot study indicated the existence of an RBC membrane barrier to oxygen (O-2) transport in the presence of hypercholesterolemia. Our current objective was to determine whether, and to what extent, the plasma cholesterol concentration is an influencing factor in RBC O-2 release and cellular O-2 availability. Study Design: In an unique 02 diffusion analysis system, blood samples from 100 patients referred for lipid modification were analyzed. After 1 to 2 minutes of mixing in our diffusion analysis system, the next 1 to 2 minutes of circulation is comparable with 1 to 2 seconds of myocardial capillary flow. RBC O-2 diffusion was defined by the depletion rate of total O-2 content in blood from full O-2 saturation (98%) to desaturation (approximately 60%). Relative tissue O-2 availability was defined as the percentage decrease in O-2 availability between the high-cholesterol group and the low-cholesterol group. Results: The 100 patients were divided almost equally into two groups on the basis of plasma cholesterol ranges of 175 to 229 mg/dL (n = 49) and 230 to 293 mg/dL (n = 51). The mean cholesterol concentrations and percentage increases in the high-cholesterol group over the low-cholesterol group were: for plasma, 206 +/- 0.3 and 256+/-0.4 mg/dL, 24.3% (p < 0.001); for RBCs, 93 +/- 0.2 and 106 +/- 0.2 mg/dL, 14.0% (p < 0.001); and for RBC membranes, 41 +/- 0.1 and 54 +/- 0.2 mg/dL, 31.7% (p < 0.001). The blood 02 diffusion curves were distinctly different between the high- and the low-cholesterol groups (p < 0.05). Blood O-2 diffusion, defined by the blood O-2 diffusion curves, was inversely proportional to the plasma, RBC,and RBC-membrane cholesterol concentrations. The relative tissue O-2 availability, after a circulation period of more than 3 minutes in the diffusion system, showed a decrease of 17.5% (p < 0.05) between the plasma cholesterol groups. In comparing the two plasma cholesterol concentration extremes of less than 200 mg/dL (n = 14) and greater than 275 mg/dL (n = 11) after a circulation period of more than 3 minutes in the diffusion system, we found a decrease in relative tissue O-2 availability of 35.8% (p < 0.05). Conclusions: The plasma cholesterol concentration may be an influencing factor in RBC-membrane cholesterol content, which, in turn, may regulate RBC-membrane O-2 transport, RBC O-2 release, and cellular 02 availability. The implications of this work include the addition of angina pectoris control to the indications for appropriate lipid modification and the development of an in vitro blood stress test to replace patient cardiac stress testing. (J Am Coll Surg 2000; 191:490-497 (C) 2000 by the American College of Surgeons).
引用
收藏
页码:490 / 497
页数:8
相关论文
共 22 条
[1]  
ABELL LL, 1952, J BIOL CHEM, V195, P357
[2]  
ALLAIN CC, 1974, CLIN CHEM, V20, P470
[3]  
Andrews TC, 1997, CIRCULATION, V95, P324
[4]   CORONARY ANGIOGRAPHIC CHANGES WITH LOVASTATIN THERAPY - THE MONITORED ATHEROSCLEROSIS REGRESSION STUDY (MARS) [J].
BLANKENHORN, DH ;
AZEN, SP ;
KRAMSCH, DM ;
MACK, WJ ;
CASHINHEMPHILL, L ;
HODIS, HN ;
DEBOER, LWV ;
MAHRER, PR ;
MASTELLER, MJ ;
VAILAS, LI ;
ALAUPOVIC, P ;
HIRSCH, LJ .
ANNALS OF INTERNAL MEDICINE, 1993, 119 (10) :969-976
[5]   EFFECT OF PARTIAL ILEAL BYPASS-SURGERY ON MORTALITY AND MORBIDITY FROM CORONARY HEART-DISEASE IN PATIENTS WITH HYPERCHOLESTEROLEMIA - REPORT OF THE PROGRAM ON THE SURGICAL CONTROL OF THE HYPERLIPIDEMIAS (POSCH) [J].
BUCHWALD, H ;
VARCO, RL ;
MATTS, JP ;
LONG, JM ;
FITCH, LL ;
CAMPBELL, GS ;
PEARCE, MB ;
YELLIN, AE ;
EDMISTON, WA ;
SMINK, RD ;
SAWIN, HS ;
CAMPOS, CT ;
HANSEN, BJ ;
TUNA, N ;
KARNEGIS, JN ;
SANMARCO, ME ;
AMPLATZ, K ;
CASTANEDAZUNIGA, WR ;
HUNTER, DW ;
BISSETT, JK ;
WEBER, FJ ;
STEVENSON, JW ;
LEON, AS ;
CHALMERS, TC .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (14) :946-955
[6]  
CAZANA FJD, 1990, INT J VITAM NUTR RES, V60, P392
[7]   Effect of supplemental oral L-arginine on exercise capacity in patients with stable angina pectoris [J].
Ceremuzynski, L ;
Chamiec, T ;
HerbaczynskaCedro, K .
AMERICAN JOURNAL OF CARDIOLOGY, 1997, 80 (03) :331-&
[8]   Effects of short-term reduction in serum cholesterol with simvastatin in patients with stable angina pectoris and mild to moderate hypercholesterolemia [J].
deDivitiis, M ;
Rubba, P ;
DiSomma, S ;
Liguori, V ;
Galderisi, M ;
Montefusco, S ;
Carreras, G ;
Vincenzo, G ;
Carotenuto, A ;
Iannuzzo, G ;
deDivitiis, O .
AMERICAN JOURNAL OF CARDIOLOGY, 1996, 78 (07) :763-768
[9]  
GUYTON AC, 1991, TXB MED PHYSL, P237
[10]  
HARRISON DG, 1987, J CLIN INVEST, V83, P465